Goldman Sachs’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $373M | Buy |
|
|||||
|
2025
Q2 | $317M | Sell |
|
|||||
|
2025
Q1 | $346M | Buy |
|
|||||
|
2024
Q4 | $365M | Sell |
|
|||||
|
2024
Q3 | $537M | Buy |
|
|||||
|
2024
Q2 | $617M | Sell |
|
|||||
|
2024
Q1 | $663M | Buy |
|
|||||
|
2023
Q4 | $479M | Buy |
|
|||||
|
2023
Q3 | $389M | Buy |
|
|||||
|
2023
Q2 | $301M | Sell |
|
|||||
|
2023
Q1 | $301M | Sell |
|
|||||
|
2022
Q4 | $258M | Buy |
|
|||||
|
2022
Q3 | $188M | Buy |
|
|||||
|
2022
Q2 | $199M | Buy |
|
|||||
|
2022
Q1 | $190M | Buy |
|
|||||
|
2021
Q4 | $171M | Sell |
|
|||||
|
2021
Q3 | $159M | Buy |
|
|||||
|
2021
Q2 | $105M | Buy |
|
|||||
|
2021
Q1 | $74.9M | Buy |
|
|||||
|
2020
Q4 | $72.4M | Buy |
|
|||||
|
2020
Q3 | $68.6M | Sell |
|
|||||
|
2020
Q2 | $66.3M | Buy |
|
|||||
|
2020
Q1 | $57.8M | Sell |
|
|||||
|
2019
Q4 | $59.4M | Sell |
|
|||||
|
2019
Q3 | $53.9M | Buy |
|
|||||
|
2019
Q2 | $50.9M | Sell |
|
|||||
|
2019
Q1 | $55.1M | Sell |
|
|||||
|
2018
Q4 | $53M | Buy |
|
|||||
|
2018
Q3 | $53M | Buy |
|
|||||
|
2018
Q2 | $42M | Buy |
|
|||||
|
2018
Q1 | $44.2M | Sell |
|
|||||
|
2017
Q4 | $49.2M | Sell |
|
|||||
|
2017
Q3 | $47.7M | Buy |
|
|||||
|
2017
Q2 | $38.9M | Buy |
|
|||||
|
2017
Q1 | $28.1M | Buy |
|
|||||
|
2016
Q4 | $26.1M | Sell |
|
|||||
|
2016
Q3 | $32.3M | Buy |
|
|||||
|
2016
Q2 | $40.8M | Sell |
|
|||||
|
2016
Q1 | $43.2M | Buy |
|
|||||
|
2015
Q4 | $41.9M | Buy |
|
|||||
|
2015
Q3 | $34.4M | Buy |
|
|||||
|
2015
Q2 | $33.8M | Buy |
|
|||||
|
2015
Q1 | $31.4M | Sell |
|
|||||
|
2014
Q4 | $27.3M | Buy |
|
|||||
|
2014
Q3 | $28.3M | Buy |
|
|||||
|
2014
Q2 | $23.6M | Sell |
|
|||||
|
2014
Q1 | $23.6M | Buy |
|
|||||
|
2013
Q4 | $14.8M | Buy |
|
|||||
|
2013
Q3 | $12M | Buy |
|
|||||
|
2013
Q2 | $9.68M | Buy |
|